TippingPoint Biosciences
TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.
$4.5M Seed ·
Source: Pulse 2.0
All 3 rounds ↓Signals
Website registeredSep 15, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $4.5M | — | Pulse 2.0 | |
| Pre Seed | undisclosed | — | fundraisingfox.com |
Timeline
- IndieBio SF 14
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
LH
Laura Hsieh Founder
Investors
Companies like TippingPoint Biosciences
HHotSpot Therapeutics$100M Series B+ · Nov 2021
IInocras$31M Series B+ · Aug 2026
OOrchidSeedAActio Biosciences$66M Series B+ · Jun 2025
MMerida Biosciences$120M Series A · May 2025
EExeliom BiosciencesSeries A · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tippingpoint-biosciences (get a free API key).